Beausang Ellen 4
4 · Aspira Women's Health Inc. · Filed Apr 1, 2025
Insider Transaction Report
Form 4
Beausang Ellen
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-31+1,615→ 1,615 total - Exercise/Conversion
Restricted Stock Units
2025-03-31−1,615→ 4,843 total→ Common Stock (1,615 underlying)
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock
- [F3]On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.